| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K49290616 | CTRPv2 | pan-cancer | AAC | 0.096 | 0.2 |
| mRNA | BRD-A02303741:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.047 | 0.2 |
| mRNA | CCT007093 | GDSC1000 | pan-cancer | AAC | -0.041 | 0.2 |
| mRNA | dabrafenib | GDSC1000 | pan-cancer | AAC | -0.036 | 0.2 |
| mRNA | tivozanib | GDSC1000 | pan-cancer | AAC | -0.041 | 0.2 |
| mRNA | TL-2-105 | GDSC1000 | pan-cancer | AAC | 0.039 | 0.2 |
| mRNA | 968 | CTRPv2 | pan-cancer | AAC | 0.085 | 0.2 |
| mRNA | KIN001-270 | GDSC1000 | pan-cancer | AAC | 0.04 | 0.2 |
| mRNA | PD-0332991 | CCLE | pan-cancer | AAC | -0.058 | 0.2 |
| mRNA | WH-4-023 | GDSC1000 | pan-cancer | AAC | -0.059 | 0.2 |